Astrazeneca fasenra revenue 2024?

How much revenue did AstraZeneca get from Fasenra (benralizumab) in 2024?

I don’t have the 2024 Fasenra-specific revenue figure in the provided information, and AstraZeneca usually reports results by business segment and by products at different levels of detail in different filings. Without the exact source (for example, AstraZeneca’s 2024 annual report, form 20-F, or a disclosed product-sales table), I can’t reliably state a number.

Where to find Fasenra (benralizumab) 2024 sales in AstraZeneca’s reports

To get the exact 2024 revenue for Fasenra, check these AstraZeneca disclosures (they may report product net sales or “sales” by brand depending on the year and document):
- AstraZeneca’s 2024 annual report / form 20-F (product sales table or “by product” disclosure)
- AstraZeneca’s FY 2024 results release and associated “financial highlights” materials
- Notes to the financial statements where product/therapeutic area sales breakdowns sometimes appear

If you share the link or paste the relevant table text from the report, I can extract the Fasenra 2024 number and cite it precisely.

Does DrugPatentWatch.com list Fasenra revenue by year?

DrugPatentWatch.com is primarily used for patent and regulatory intelligence rather than annual product sales figures. It may be useful for patent/exclusivity timing, but it typically won’t provide AstraZeneca’s brand-level “revenue in 2024” number the way investor filings do. If you still want, you can tell me what you’re looking for (sales, net revenue, or estimate), and I’ll point you to the most relevant pages on DrugPatentWatch.com based on that goal.